Lv1
70 积分 2020-05-19 加入
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
1个月前
已完结
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses
1个月前
已完结
Characteristics and Evolution of Extraintestinal Manifestations Associated with Ulcerative Colitis after Proctocolectomy
2个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
2个月前
已完结
Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease
2个月前
已完结
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
2个月前
已完结
P469 Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects
2个月前
已完结
Nivolumab for Patients With High-Risk Oral Leukoplakia
3个月前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
3个月前
已完结
Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
4个月前
已完结
皖公网安备34019202002308
